Quick Answer
Aquestive Therapeutics, Inc. reported Shares Outstanding of 122.04 million shares for fiscal year 2025.
Aquestive Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 122.04M | +33.5% |
| 2024 | 91.41M | +33.4% |
| 2023 | 68.53M | +25.0% |
| 2022 | 54.83M | +33.0% |
| 2021 | 41.23M | +19.3% |
| 2020 | 34.57M | +3.0% |
| 2019 | 33.56M | +34.5% |
| 2018 | 24.96M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 121.66M | +33.4% | +22.5% |
| June 30, 2025 | 99.35M | +9.1% | +0.0% |
| March 31, 2025 | 99.32M | +9.8% | +8.6% |
| December 31, 2024 | 91.41M | +33.4% | +0.3% |
| September 30, 2024 | 91.18M | +36.6% | +0.1% |
| June 30, 2024 | 91.06M | +47.8% | +0.6% |
| March 31, 2024 | 90.48M | +61.8% | +32.0% |
| December 31, 2023 | 68.53M | +25.0% | +2.7% |
- Aquestive Therapeutics, Inc. showed an increase of +33.5% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Aquestive Therapeutics, Inc.’s shares outstanding has grown by 389.0% (from 24.96 million shares to 122.04 million shares).
- The most recent figure is from Aquestive Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: